CYTOSORBENTS CORPORATION Proceeds from Long-Term Debt Issued
CYTOSORBENTS CORPORATION (CTSO) reported Proceeds from Long-Term Debt Issued of $2.48 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfLongTermDebt · last filed 2026-03-30
- CYTOSORBENTS CORPORATION proceeds from issuance of long-term debt for the quarter ending 2024-12-31 was $0.00.
- CYTOSORBENTS CORPORATION proceeds from issuance of long-term debt for the quarter ending 2024-09-30 was $0.00.
- CYTOSORBENTS CORPORATION proceeds from issuance of long-term debt for the quarter ending 2021-09-30 was $0.00.
- CYTOSORBENTS CORPORATION proceeds from issuance of long-term debt for the quarter ending 2020-12-31 was $0.00.
- CYTOSORBENTS CORPORATION proceeds from issuance of long-term debt for fiscal 2025 was $2.48M, a 83.48% decline from fiscal 2024.
- CYTOSORBENTS CORPORATION proceeds from issuance of long-term debt for fiscal 2024 was $15.00M.
- CYTOSORBENTS CORPORATION proceeds from issuance of long-term debt for fiscal 2022 was $5.00M.
- CYTOSORBENTS CORPORATION proceeds from issuance of long-term debt for fiscal 2020 was $1.41M, a 71.78% decline from fiscal 2019.
| Period end | Proceeds from Issuance of Long-term Debt 3 month | Proceeds from Issuance of Long-term Debt 6 month | Proceeds from Issuance of Long-term Debt 9 month | Proceeds from Issuance of Long-term Debt 12 month |
|---|---|---|---|---|
| 2025-12-31 | $2.48M 10-K · filed 2026-03-30 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $0.00 derived: sum of 2 quarters · filed 2026-03-30 | $15.00M 10-K · filed 2026-03-30 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $15.00M 10-Q · filed 2025-11-13 | ||
| 2024-06-30 | $15.00M 10-Q · filed 2025-08-07 | |||
| 2022-12-31 | $5.00M 10-K · filed 2024-03-15 | |||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $0.00 10-Q · filed 2021-11-04 | ||
| 2021-06-30 | $0.00 10-Q · filed 2021-08-03 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $0.00 derived: sum of 2 quarters · filed 2023-03-09 | $1.41M 10-K · filed 2023-03-09 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $1.41M 10-Q · filed 2021-11-04 | ||
| 2020-06-30 | $1.41M 10-Q · filed 2021-08-03 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $5.00M derived: sum of 2 quarters · filed 2022-03-10 | $5.00M derived: sum of 3 quarters · filed 2022-03-10 | $5.00M 10-K · filed 2022-03-10 |
| 2019-09-30 | $5.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | $5.00M derived: sum of 2 quarters · filed 2020-11-04 | $5.00M 10-Q · filed 2020-11-04 | $5.00M derived: sum of 4 quarters · filed 2021-03-09 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $0.00 10-Q · filed 2020-08-04 | $0.00 derived: sum of 3 quarters · filed 2021-03-09 | $0.00 derived: sum of 4 quarters · filed 2021-03-09 |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-07 | $0.00 derived: sum of 2 quarters · filed 2021-03-09 | $0.00 derived: sum of 3 quarters · filed 2021-03-09 | $0.00 derived: sum of 4 quarters · filed 2021-03-09 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-09 | $0.00 derived: sum of 2 quarters · filed 2021-03-09 | $0.00 derived: sum of 3 quarters · filed 2021-03-09 | $666.67K 10-K · filed 2021-03-09 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $0.00 derived: sum of 2 quarters · filed 2019-11-05 | $666.67K 10-Q · filed 2019-11-05 | $666.67K derived: sum of 4 quarters · filed 2020-03-05 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $666.67K 10-Q · filed 2019-08-06 | $666.67K derived: sum of 3 quarters · filed 2020-03-05 | $666.67K derived: sum of 4 quarters · filed 2020-03-05 |
| 2018-03-31 | $666.67K 10-Q · filed 2019-05-07 | $666.67K derived: sum of 2 quarters · filed 2020-03-05 | $666.67K derived: sum of 3 quarters · filed 2020-03-05 | $5.67M derived: sum of 4 quarters · filed 2020-03-05 |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-05 | $0.00 derived: sum of 2 quarters · filed 2020-03-05 | $5.00M derived: sum of 3 quarters · filed 2020-03-05 | $5.00M 10-K · filed 2020-03-05 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $5.00M derived: sum of 2 quarters · filed 2018-11-06 | $5.00M 10-Q · filed 2018-11-06 | $5.00M derived: sum of 4 quarters · filed 2019-03-07 |
| 2017-06-30 | $5.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $5.00M 10-Q · filed 2018-08-02 | $5.00M derived: sum of 3 quarters · filed 2019-03-07 | $5.00M derived: sum of 4 quarters · filed 2019-03-07 |
| 2017-03-31 | $0.00 10-Q · filed 2018-05-08 | $0.00 derived: sum of 2 quarters · filed 2019-03-07 | $0.00 derived: sum of 3 quarters · filed 2019-03-07 | |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $0.00 derived: sum of 2 quarters · filed 2019-03-07 | $5.00M 10-K · filed 2019-03-07 | |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $5.00M 10-Q · filed 2017-11-09 | ||
| 2016-06-30 | $5.00M 10-Q · filed 2017-08-07 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $0.00 derived: sum of 2 quarters · filed 2018-03-08 | $0.00 10-K · filed 2018-03-08 | |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $0.00 10-Q · filed 2016-11-07 | ||
| 2015-06-30 | $0.00 10-Q · filed 2016-08-09 | |||
| 2014-12-31 | $0.00 10-K · filed 2017-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |